CONVERTIBLE NOTE DUE [*], 20[*]Cell Source, Inc. • April 14th, 2016 • Pharmaceutical preparations • New York
THIS CONVERTIBLE NOTE is one of a series of a duly authorized and validly issued Convertible Notes of Cell Source, Inc., a Nevada corporation (the “Company”), having its principal place of business at 65 Yigal Alon Street, Tel Aviv, Israel 67433, designated as its Convertible Note due [*], 20[*] (this Note, the “Note” and, collectively with the other Notes of such series, the “Notes”).
SUBSCRIPTION AGREEMENTSubscription Agreement • April 14th, 2016 • Cell Source, Inc. • Pharmaceutical preparations • New York
The undersigned (the “Investor”) hereby confirms its agreement with Cell Source, Inc., a Nevada corporation (the “Company”), as follows:
